FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention concerns agent for oral administration with combined normalizing effect on immune and digestive system, which contains as active agent contains mixture of carboxylic acids, C1-C4, amino acids and their salts in the following proportions, wt%: alanine – 0.1–0.4, aspartic acid – 0.05–2.0; valine – 0.5–1.5, glycine – 0.05–0.2; glutamic acid – 0.5–2.0; leucine – 0.1–0.4; lysine hydrochloride – 0.5–2.0; carboxylic acids C1-C4 from 1.5 to 25; water – the rest, and as carboxylic acids C1-C4 it contains acetic, lactic, succinic and formic acids, wherein their concentration in end product is in range, wt%: acetic acid – 1.0–15.0 %; lactic acid – 0.2–5.0 %; succinic acid – 0.15–3.0 %; formic acid – 0.1–2.0 %.
EFFECT: invention provides stimulation of cell immune response, intensified humoral immune response and also has therapeutic action in erosive-ulcerous lesions of gastrointestinal tract.
1 cl, 9 ex, 11 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD AND DEVICE FOR MODULATING IMMUNE RESPONSE | 1999 |
|
RU2225197C2 |
METHOD FOR PRODUCING POLARIZED LYMPHOCYTES FOR MODELING Th2-INDUCED EDEMA | 2006 |
|
RU2318525C1 |
MUCOSAL INDUCTION OF ANTIGEN TOLERANCE | 2006 |
|
RU2420569C2 |
IMMUNOMODULATING AGENT | 2003 |
|
RU2245142C1 |
APPLICATION OF MYCOBACTERIUM VACCAE FOR FEEDBACK INHIBITION REGULATION OF TH2-ACTIVITY OF IMMUNE SYSTEM | 1997 |
|
RU2197989C2 |
IMMUNOMODULATOR | 2003 |
|
RU2252757C1 |
IMMUNODEPRESSANT | 2002 |
|
RU2228178C1 |
IMMUNOMODULATOR | 2003 |
|
RU2253444C1 |
IMMUNOMODULATING AGENT | 2003 |
|
RU2240794C1 |
METHOD OF SELECTIVE DESTRUCTION OF MACROPHAGES IN CELL SUSPENSION AND WHOLE ORGANISM USING COLLOIDAL SILVER PREPARATIONS - PROTARGOL AND COLLARGOL | 2022 |
|
RU2811772C2 |
Authors
Dates
2017-02-21—Published
2015-03-26—Filed